Thomas Engström (Former)
1 – 37 of 37
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Familial clustering of unexplained heart failure – A Danish nationwide cohort study
2024) In International Journal of Cardiology(
- Contribution to journal › Article
-
Mark
A randomised trial of selective intracoronary hypothermia during primary PCI
(
- Contribution to journal › Article
- 2022
-
Mark
On the Natural History of Coronary Artery Disease : A Longitudinal Nationwide Serial Angiography Study
(
- Contribution to journal › Article
-
Mark
Clinical outcomes of no stenting in patients with ST-segment elevation myocardial infarction undergoing deferred primary percutaneous coronary intervention
(
- Contribution to journal › Article
-
Mark
Comparison of Effect of Ischemic Postconditioning on Cardiovascular Mortality in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention With Versus Without Thrombectomy
(
- Contribution to journal › Article
- 2021
-
Mark
Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II) : a prospective natural history study
(
- Contribution to journal › Article
-
Mark
Clopidogrel, prasugrel, and ticagrelor for all-comers with ST-segment elevation myocardial infarction
(
- Contribution to journal › Article
-
Mark
Clinical outcome following late reperfusion with percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction
(
- Contribution to journal › Article
-
Mark
Long-term prognostic outcomes and implication of oral anticoagulants in patients with new-onset atrial fibrillation following st-segment elevation myocardial infarction
(
- Contribution to journal › Article
- 2020
-
Mark
Sibling history is associated with heart failure after a first myocardial infarction
(
- Contribution to journal › Article
-
Mark
Early Q-wave morphology in prediction of reperfusion success in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention – A cardiac magnetic resonance imaging study
(
- Contribution to journal › Article
-
Mark
Potassium Disturbances and Risk of Ventricular Fibrillation Among Patients With ST-Segment-Elevation Myocardial Infarction
(
- Contribution to journal › Article
-
Mark
Sub-acute cardiac magnetic resonance to predict irreversible reduction in left ventricular ejection fraction after ST-segment elevation myocardial infarction : A DANAMI-3 sub-study
(
- Contribution to journal › Article
-
Mark
Vascular function in adults with cyanotic congenital heart disease
(
- Contribution to journal › Article
-
Mark
Using proximity extension proteomics assay to identify biomarkers associated with infarct size and ejection fraction after ST-elevation myocardial infarction
(
- Contribution to journal › Article
-
Mark
Usefulness of High Sensitivity Troponin T to Predict Long-Term Left Ventricular Dysfunction After ST-Elevation Myocardial Infarction
(
- Contribution to journal › Article
-
Mark
Evaluation and Management of Nonculprit Lesions in STEMI
(
- Contribution to journal › Scientific review
-
Mark
Percutaneous Coronary Intervention for Vulnerable Coronary Atherosclerotic Plaque
(
- Contribution to journal › Article
-
Mark
Seasonality of ventricular fibrillation at first myocardial infarction and association with viral exposure
(
- Contribution to journal › Article
- 2019
-
Mark
Subclinical atherosclerosis in patients with cyanotic congenital heart disease
(
- Contribution to journal › Article
-
Mark
Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease : A DANAMI-3–PRIMULTI Cardiac Magnetic Resonance Substudy
(
- Contribution to journal › Article
-
Mark
Unreported exclusion and sampling bias in interpretation of randomized controlled trials in patients with STEMI
(
- Contribution to journal › Article
-
Mark
Fractional flow reserve-guided percutaneous coronary intervention vs. medical therapy for patients with stable coronary lesions : meta-analysis of individual patient data
(
- Contribution to journal › Article
-
Mark
Subsequent Event Risk in Individuals With Established Coronary Heart Disease
(
- Contribution to journal › Article
-
Mark
Impact of Multiple Myocardial Scars Detected by CMR in Patients Following STEMI
(
- Contribution to journal › Article
- 2018
-
Mark
Benefit From Reperfusion With Primary Percutaneous Coronary Intervention Beyond 12 Hours of Symptom Duration in Patients With ST-Segment-Elevation Myocardial Infarction
(
- Contribution to journal › Article
-
Mark
Predictive Value of High-Sensitivity Troponin T for Systolic Dysfunction and Infarct Size (Six Months) After ST-Elevation Myocardial Infarction
(
- Contribution to journal › Article
-
Mark
Impact of diagnostic ECG-to-wire delay in STEMI patients treated with primary PCI : A DANAMI-3 substudy
(
- Contribution to journal › Article
-
Mark
A comprehensive evaluation of the genetic architecture of sudden cardiac arrest
(
- Contribution to journal › Article
-
Mark
Comparison between patients included in randomized controlled trials of ischemic heart disease and real-world data. A nationwide study
(
- Contribution to journal › Article
-
Mark
Bleeding Events After ST-segment Elevation Myocardial Infarction in Patients Randomized to an All-comer Clinical Trial Compared With Unselected Patients
(
- Contribution to journal › Article
-
Mark
Danegaptide for primary percutaneous coronary intervention in acute myocardial infarction patients : A phase 2 randomised clinical trial
(
- Contribution to journal › Article
- 2017
-
Mark
The Compare-Acute trial of fractional flow reserve-guided multivessel angioplasty in myocardial infarction
(
- Contribution to journal › Article
-
Mark
Association of common genetic variants related to atrial fibrillation and the risk of ventricular fibrillation in the setting of first ST-elevation myocardial infarction
(
- Contribution to journal › Article
-
Mark
Design and rationale for the Influenza vaccination After Myocardial Infarction (IAMI) trial. A registry-based randomized clinical trial
(
- Contribution to journal › Article
-
Mark
Intravenous beta-blocker therapy in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention is not associated with benefit regarding short-term mortality : A Swedish nationwide observational study
(
- Contribution to journal › Article
- 2015
-
Mark
Prehospital administration of P2Y12 inhibitors and early coronary reperfusion in primary PCI : an observational comparative study
(
- Contribution to journal › Article